CRISPR-based engineering of next-generation lactic acid bacteria

Current Opinion in Microbiology

Volumn 37, Issue , 2017, Pages 79-87

  Hidalgo Cantabrana, Claudio ^a   O'Flaherty, Sarah ^a   Barrangou, Rodolphe ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRISPR ASSOCIATED PROTEIN; LACTOBACILLUS VACCINE; PROBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL GENOME; BIFIDOBACTERIUM; CELL ENGINEERING; CELL SURFACE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; DRUG DELIVERY DEVICE; FERMENTED PRODUCT; GENE EDITING; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; LACTIC ACID BACTERIUM; LACTOBACILLUS; NONHUMAN; REVIEW; TRANSCRIPTION INITIATION; CRISPR CAS SYSTEM; FOOD CONTROL; GENETICS; METABOLIC ENGINEERING; PHYSIOLOGY; PROCEDURES;

BIFIDOBACTERIUM; CRISPR-CAS SYSTEMS; FOOD MICROBIOLOGY; GENE EDITING; HUMANS; LACTOBACILLUS; METABOLIC ENGINEERING; PROBIOTICS;

EID: 85020738237     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2017.05.015     Document Type: Review

References (65)

1. Barrangou, R., Doudna, J.A., Applications of CRISPR technologies in research and beyond. Nat Biotechnol 34 (2016), 933–941.
2. Price, V.J., Huo, W., Sharifi, A., Palmer, K.L., CRISPR–Cas and restriction-modification act additively against conjugative antibiotic resistance plasmid transfer in Enterococcus faecalis. mSphere, 2016, 1.
3. Grissa, I., Vergnaud, G., Pourcel, C., The CRISPRdb database and tools to display CRISPRs and to generate dictionaries of spacers and repeats. BMC Bioinformatics, 8, 2007, 172.
4. Ishino, Y., Shinagawa, H., Makino, K., Amemura, M., Nakata, A., Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol 169 (1987), 5429–5433.
5. Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D.A., Horvath, P., CRISPR provides acquired resistance against viruses in prokaryotes. Science 315 (2007), 1709–1712.
6. Barrangou, R., Dudley, E.G., CRISPR-based typing and next-generation tracking technologies. Annu Rev Food Sci Technol 7 (2016), 395–411.
7. Gogleva, A.A., Gelfand, M.S., Artamonova, I.I., Comparative analysis of CRISPR cassettes from the human gut metagenomic contigs. BMC Genomics, 15, 2014, 202.
8. Stern, A., Mick, E., Tirosh, I., Sagy, O., Sorek, R., CRISPR targeting reveals a reservoir of common phages associated with the human gut microbiome. Genome Res 22 (2012), 1985–1994.
9. Wang, J., Gao, Y., Zhao, F., Phage–bacteria interaction network in human oral microbiome. Environ Microbiol 18 (2016), 2143–2158.
10. Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J.A., Charpentier, E., A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337 (2012), 816–821.
11. Barrangou, R., van Pijkeren, J.P., Exploiting CRISPR–Cas immune systems for genome editing in bacteria. Curr Opin Biotechnol 37 (2016), 61–68.
12. 12• Komor, A.C., Badran, A.H., Liu, D.R., CRISPR-based technologies for the manipulation of eukaryotic genomes. Cell, 169, 2017, 559 This study established the sgRNA:Cas9 technology, as a portable variant of the native CRISPR–Cas system.
13. FAO/WHO: Guidelines for the Evaluation of Probiotics in Food. 2002 http://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf.
14. Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11 (2014), 506–514.
15. Authority, E.F.S., Guidance on the scientific requirements for health claims related to the immune system, the gastrointestinal tract and defence against pathogenic microorganisms. EFSA J, 14, 2016, 23.
16. Tojo, R., Suarez, A., Clemente, M.G., de los Reyes-Gavilan, C.G., Margolles, A., Gueimonde, M., Ruas-Madiedo, P., Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis. World J Gastroenterol 20 (2014), 15163–15176.
17. Vlasova, A.N., Kandasamy, S., Chattha, K.S., Rajashekara, G., Saif, L.J., Comparison of probiotic lactobacilli and bifidobacteria effects, immune responses and rotavirus vaccines and infection in different host species. Vet Immunol Immunopathol 172 (2016), 72–84.
18. Sun, Z., Harris, H.M., McCann, A., Guo, C., Argimon, S., Zhang, W., Yang, X., Jeffery, I.B., Cooney, J.C., Kagawa, T.F., et al. Expanding the biotechnology potential of lactobacilli through comparative genomics of 213 strains and associated genera. Nat Commun, 6, 2015, 8322.
19. Briner, A.E., Lugli, G.A., Milani, C., Duranti, S., Turroni, F., Gueimonde, M., Margolles, A., van Sinderen, D., Ventura, M., Barrangou, R., Occurrence and diversity of CRISPR–Cas systems in the genus Bifidobacterium. PLOS ONE, 10, 2015 e0133661.
20. Horvath, P., Coute-Monvoisin, A.C., Romero, D.A., Boyaval, P., Fremaux, C., Barrangou, R., Comparative analysis of CRISPR loci in lactic acid bacteria genomes. Int J Food Microbiol 131 (2009), 62–70.
21. Millen, A.M., Horvath, P., Boyaval, P., Romero, D.A., Mobile CRISPR/Cas-mediated bacteriophage resistance in Lactococcus lactis. PLoS ONE, 7, 2012 e51663.
22. Makarova, K.S., Wolf, Y.I., Alkhnbashi, O.S., Costa, F., Shah, S.A., Saunders, S.J., Barrangou, R., Brouns, S.J., Charpentier, E., Haft, D.H., et al. An updated evolutionary classification of CRISPR–Cas systems. Nat Rev Microbiol 13 (2015), 722–736.
23. 23•• Luo, M.L., Mullis, A.S., Leenay, R.T., Beisel, C.L., Repurposing endogenous type I CRISPR–Cas systems for programmable gene repression. Nucleic Acids Res 43 (2015), 674–681 This report exemplifies how native CRISPR–Cas systems can be repurposed for transcriptional control.
24. Kim, J., Kim, J.S., Bypassing GMO regulations with CRISPR gene editing. Nat Biotechnol 34 (2016), 1014–1015.
25. 25• Selle, K., Klaenhammer, T.R., Barrangou, R., CRISPR-based screening of genomic island excision events in bacteria. Proc Natl Acad Sci U S A 112 (2015), 8076–8081 This manuscript provided a proof of concept to use endogenous CRISPR–Cas systems for screening of rare mutation events in bacterial populations.
26. Ruas-Madiedo, P., Sánchez, B., Hidalgo-Cantabrana, C., Margolles, A., Laws, A., Exopolysaccharides from lactic acid bacteria and bifidobacteria. Hui, Y.H., Evranuz, E.O., (eds.) Handbook of animal-based fermented food and beverage technology, 2nd Ed., 2012, CRC Press, Florida, USA, 125–152 (Print ISBN: 978-1-4398-5022-0, eBook ISBN: 978-1-4398-5023-7, http://dx.doi.org/10.1201/b12084-9).
27. Hidalgo-Cantabrana, C., Sanchez, B., Alvarez-Martin, P., Lopez, P., Martinez-Alvarez, N., Delley, M., Marti, M., Varela, E., Suarez, A., Antolin, M., et al. A single mutation in the gene responsible for the mucoid phenotype of Bifidobacterium animalis subsp. lactis confers surface and functional characteristics. Appl Environ Microbiol 81 (2015), 7960–7968.
28. Sanozky-Dawes, R., Selle, K., O'Flaherty, S., Klaenhammer, T., Barrangou, R., Occurrence and activity of a type II CRISPR–Cas system in Lactobacillus gasseri. Microbiology 161 (2015), 1752–1761.
29. Kim, J.Y., Wang, Y., Park, M.S., Ji, G.E., Improvement of transformation efficiency through in vitro methylation and SacII site mutation of plasmid vector in Bifidobacterium longum MG1. J Microbiol Biotechnol 20 (2010), 1022–1026.
30. Goh, Y.J., Klaenhammer, T.R., Genetic mechanisms of prebiotic oligosaccharide metabolism in probiotic microbes. Annu Rev Food Sci Technol 6 (2015), 137–156.
31. Sela, D.A., Chapman, J., Adeuya, A., Kim, J.H., Chen, F., Whitehead, T.R., Lapidus, A., Rokhsar, D.S., Lebrilla, C.B., German, J.B., et al. The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc Natl Acad Sci U S A 105 (2008), 18964–18969.
32. Oh, J.H., van Pijkeren, J.P., CRISPR–Cas9-assisted recombineering in Lactobacillus reuteri. Nucleic Acids Res, 42, 2014, e131.
33. Johnson, B., Selle, K., O'Flaherty, S., Goh, Y.J., Klaenhammer, T., Identification of extracellular surface-layer associated proteins in Lactobacillus acidophilus NCFM. Microbiology 159 (2013), 2269–2282.
34. Johnson, B.R., Hymes, J., Sanozky-Dawes, R., Henriksen, E.D., Barrangou, R., Klaenhammer, T.R., Conserved S-layer-associated proteins revealed by exoproteomic survey of S-layer-forming lactobacilli. Appl Environ Microbiol 82 (2015), 134–145.
35. Ruiz, L., Margolles, A., Sanchez, B., Bile resistance mechanisms in Lactobacillus and Bifidobacterium. Front Microbiol, 4, 2013, 396.
36. Ruiz, L., Delgado, S., Ruas-Madiedo, P., Margolles, A., Sanchez, B., Proteinaceous molecules mediating Bifidobacterium–host interactions. Front Microbiol, 7, 2016, 1193.
37. Hidalgo-Cantabrana, C., Sanchez, B., Milani, C., Ventura, M., Margolles, A., Ruas-Madiedo, P., Genomic overview and biological functions of exopolysaccharide biosynthesis in Bifidobacterium spp. Appl Environ Microbiol 80 (2014), 9–18.
38. Goh, Y.J., Klaenhammer, T.R., A functional glycogen biosynthesis pathway in Lactobacillus acidophilus: expression and analysis of the glg operon. Mol Microbiol 89 (2013), 1187–1200.
39. Ruiz, L., Ruas-Madiedo, P., Gueimonde, M., de Los Reyes-Gavilan, C.G., Margolles, A., Sanchez, B., How do bifidobacteria counteract environmental challenges? Mechanisms involved and physiological consequences. Genes Nutr 6 (2011), 307–318.
40. Grimm, V., Westermann, C., Riedel, C.U., Bifidobacteria–host interactions — an update on colonisation factors. Biomed Res Int, 2014, 960826.
41. Westermann, C., Gleinser, M., Corr, S.C., Riedel, C.U., A critical evaluation of bifidobacterial adhesion to the host tissue. Front Microbiol, 7, 2016, 1220.
42. Karav, S., Le Parc, A., Leite Nobrega de Moura Bell, J.M., Frese, S.A., Kirmiz, N., Block, D.E., Barile, D., Mills, D.A., Oligosaccharides released from milk glycoproteins are selective growth substrates for infant-associated bifidobacteria. Appl Environ Microbiol 82 (2016), 3622–3630.
43. Andersen, J.M., Barrangou, R., Abou Hachem, M., Lahtinen, S.J., Goh, Y.J., Svensson, B., Klaenhammer, T.R., Transcriptional analysis of oligosaccharide utilization by Bifidobacterium lactis Bl-04. BMC Genomics, 14, 2013, 312.
44. 44•• Peters, J.M., Colavin, A., Shi, H., Czarny, T.L., Larson, M.H., Wong, S., Hawkins, J.S., Lu, C.H., Koo, B.M., Marta, E., et al. A comprehensive CRISPR-based functional analysis of essential genes in bacteria. Cell 165 (2016), 1493–1506 This manuscript showed how CRISPR interference can be used to create knockdown of essential genes and study their functionality in vivo.
45. Dong, X., Jin, Y., Ming, D., Li, B., Dong, H., Wang, L., Wang, T., Wang, D., CRISPR/dCas9-mediated inhibition of gene expression in Staphylococcus aureus. J Microbiol Methods 139 (2017), 79–86.
46. Zhao, C., Shu, X., Sun, B., Construction of a dCas9-based gene knockdown system in Staphylococcus aureus. Appl Environ Microbiol, 2017 AEM.00291-17.
47. Bermudez-Humaran, L.G., Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins. Hum Vaccin 5 (2009), 264–267.
48. Iwaki, M., Okahashi, N., Takahashi, I., Kanamoto, T., Sugita-Konishi, Y., Aibara, K., Koga, T., Oral immunization with recombinant Streptococcus lactis carrying the Streptococcus mutans surface protein antigen gene. Infect Immun 58 (1990), 2929–2934.
49. Norton, P.M., Wells, J.M., Brown, H.W., Macpherson, A.M., Le Page, R.W., Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C. Vaccine 15 (1997), 616–619.
50. Wells, J.M., Wilson, P.W., Norton, P.M., Gasson, M.J., Le Page, R.W., Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge. Mol Microbiol 8 (1993), 1155–1162.
51. O'Flaherty, S., Klaenhammer, T.R., The impact of omic technologies on the study of food microbes. Annu Rev Food Sci Technol 2 (2011), 353–371.
52. Steidler, L., Neirynck, S., Huyghebaert, N., Snoeck, V., Vermeire, A., Goddeeris, B., Cox, E., Remon, J.P., Remaut, E., Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat Biotechnol 21 (2003), 785–789.
53. 53• O'Flaherty, S., Klaenhammer, T.R., Multivalent chromosomal expression of the Clostridium botulinum serotype A neurotoxin heavy-chain antigen and the Bacillus anthracis protective antigen in Lactobacillus acidophilus. Appl Environ Microbiol 82 (2016), 6091–6101 This report demonstrate how lactic acid bacteria can be manipulated for chromosomal vaccine expression.
54. Mohamadzadeh, M., Duong, T., Sandwick, S.J., Hoover, T., Klaenhammer, T.R., Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge. Proc Natl Acad Sci U S A 106 (2009), 4331–4336.
55. Mohamadzadeh, M., Duong, T., Hoover, T., Klaenhammer, T.R., Targeting mucosal dendritic cells with microbial antigens from probiotic lactic acid bacteria. Expert Rev Vaccines 7 (2008), 163–174.
56. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature, 486, 2012, 207–214.
57. Arigoni DM. Genetic remodeling in Bifidobacterium WO 2008019886 A1. US Patent; 2008.
58. Briner, A.E., Barrangou, R., Lactobacillus buchneri genotyping on the basis of clustered regularly interspaced short palindromic repeat (CRISPR) locus diversity. Appl Environ Microbiol 80 (2014), 994–1001.
59. Gomaa, A.A., Klumpe, H.E., Luo, M.L., Selle, K., Barrangou, R., Beisel, C.L., Programmable removal of bacterial strains by use of genome-targeting CRISPR–Cas systems. MBio, 5, 2014 e00928-13.
60. 60•• Westbrook, A.W., Moo-Young, M., Chou, C.P., Development of a CRISPR–Cas9 tool kit for comprehensive engineering of Bacillus subtilis. Appl Environ Microbiol 82 (2016), 4876–4895 This study illustrates the development of a CRISPR–Cas9 tool to perform gene insertion, deletions, site-specific mutations and transcriptional regulation.
61. Wang, Y., Zhang, Z.T., Seo, S.O., Lynn, P., Lu, T., Jin, Y.S., Blaschek, H.P., Bacterial genome editing with CRISPR–Cas9: deletion, integration, single nucleotide modification, and desirable “clean” mutant selection in Clostridium beijerinckii as an example. ACS Synth Biol 5 (2016), 721–732.
62. Cleto, S., Jensen, J.V., Wendisch, V.F., Lu, T.K., Corynebacterium glutamicum metabolic engineering with CRISPR interference (CRISPRi). ACS Synth Biol 5 (2016), 375–385.
63. Jiang, Y., Qian, F., Yang, J., Liu, Y., Dong, F., Xu, C., Sun, B., Chen, B., Xu, X., Li, Y., et al. CRISPR-Cpf1 assisted genome editing of Corynebacterium glutamicum. Nat Commun, 8, 2017, 15179.
64. Jiang, Y., Chen, B., Duan, C., Sun, B., Yang, J., Yang, S., Multigene editing in the Escherichia coli genome via the CRISPR–Cas9 system. Appl Environ Microbiol 81 (2015), 2506–2514.
65. Tong, Y., Charusanti, P., Zhang, L., Weber, T., Lee, S.Y., CRISPR–Cas9 based engineering of actinomycetal genomes. ACS Synth Biol 4 (2015), 1020–1029.